Compliant Analysis of Patient Samples and Data

Participation Deadline: 08/15/2030
Apply Now

Description

Arm 1 – Remnant commercial samples and data that has been de-identified of personal health information in compliance with HIPAA may be used for R&D studies or population-based analysis by LabCorp or affiliates.

Arm 2 – Collection of samples and/or data from commercial test patients requiring follow-up or from subjects of scientific interest after informed consent is obtained.